European Pharmaceutical Review

JANUARY 9, 2024

Revolutionising quality control In the backdrop of stringent quality standards and regulatory demands inherent to pharmaceutical manufacturing, the addition of AI technologies introduce a paradigm shift. AI and future perspectives: a glimpse into tomorrow Figure 2: adapted from Saha, G.

Pharmaceutical manufacturing 122

Pharmaceutical manufacturing Manufacturing Pharmaceutical Food and Drug Administration 122

European Pharmaceutical Review

JULY 21, 2023

Manufacturing delays and capacity issues that continue to impact the pharmaceutical supply chain have led to medicine shortages around the globe; an issue that has been exacerbated further by geopolitical events, the energy crisis and rising inflation. What are the top three supply-related challenges facing pharmaceutical manufacturers?

Pharmaceutical 95

Pharmaceutical Food and Drug Administration Transportation Manufacturing 95

Pharma Marketing Network

JULY 26, 2023

The Food and Drug Administration (FDA) plays a critical role in regulating the pharmaceutical industry and ensuring that medications and medical devices marketed to the public are safe, effective, and appropriately labeled.

Marketing 97

Marketing FDA Food and Drug Administration Pharmaceutical 97

European Pharmaceutical Review

MARCH 12, 2024

In the pharmaceutical/life sciences industries, maintaining data integrity is crucial given its role in making critical decisions that shape outcomes from drug development to human health. What is the biggest impact of having compromised data when working with regulatory bodies in the pharmaceutical industry?

Government 90

Government Pharma Ethics Training 90

Clarivate

NOVEMBER 13, 2023

Clinical outcome assessments can take years to generate but may pay big dividends in patient-focused drug development, centering the patient experience and potentially bolstering a product’s case with regulators and payers. We developed or explored over 100 COAs and achieved ethical approval in multiple countries including the U.S.,

Patients 52

Patients Food and Drug Administration FDA Safety 52

Pharma Marketing Network

JUNE 11, 2020

And I said, you know, I gotta reward people who I think are doing a good job in the pharmaceutical industry in terms of social media, because, at that time, there were few and far between. They would write up the presentations by physicians about drugs. So, I didn’t look so bad. So, I was actually presenting there.

Media 52

Media Pharma Ethics Consulting 52

Cadensee

JULY 20, 2021

head of digital engagement and capabilities, teva pharmaceuticals. Uri Goren is the head of digital engagement and capabilities at Teva Pharmaceuticals, and just recently became a member of the National Advisory Board for digital health for the Israel Ministry of Health. Show Notes.

Food and Drug Administration 52

Food and Drug Administration Doctors Healthcare Healthcare 52